{"id":2771,"date":"2010-04-20T03:50:34","date_gmt":"2010-04-20T03:50:34","guid":{"rendered":"https:\/\/www.cornerstone.com\/?post_type=case_study&p=2771"},"modified":"2022-06-27T11:36:26","modified_gmt":"2022-06-27T16:36:26","slug":"biogen-securities-litigation","status":"publish","type":"case_study","link":"https:\/\/www.cornerstone.com\/insights\/cases\/biogen-securities-litigation\/","title":{"rendered":"Biogen Securities Litigation"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categories":[60],"tags":[],"asset_type":[79],"class_list":["post-2771","case_study","type-case_study","status-publish","hentry","category-securities-litigation"],"acf":[],"yoast_head":"\n